DianeM.(Richtels)KarlMD

PubMed

• 44 citations
  Albuminuria and Cognitive Decline in People with Diabetes and Normal Renal Function
  Joshua I. Barzilay, James Lovato, Anne M. Murray, Jeff D. Williamson, Faramaz Ismail-Beigi, Diane Karl, Vasilios Papademetriou, Lenore J. Launer> ;Clinical Journal of the American Society of Nephrology. 2013 Nov 7
• 20 citations
  Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus.
  D. M. Karl, J. Gill, Rong Zhou, Matthew C. Riddle> ;Diabetes, Obesity & Metabolism. 2013 Jul 1
• 44 citations
  Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.
  Matthew C. Riddle, Diane M. Karl> ;Diabetes Care. 2012 Oct 1
• 7 citations
  Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
  D. Karl, Rong Zhou, A. Vlajnic, Matthew C. Riddle> ;Diabetic Medicine. 2012 Jul 1
• 59 citations
  Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
  Faramarz Ismail-Beigi, Timothy E. Craven, Patrick J. O'Connor, Diane M. Karl, Jorge Calles-Escandon, Irene Hramiak, Saul Genuth, William C. Cushman, Hertzel C. Gerstei...> ;Kidney International. 2012 Mar 2
• 942 citations
  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
  Faramarz Ismail-Beigi, Timothy E. Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M. Cohen, R. Cuddihy, William C. Cushman, Saul Genuth, Richard H. Grimm, B...> ;Lancet. 2010 Aug 7
• 24 citations
  Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.
  Diane M. Karl, Athena Philis-Tsimikas, Tamara Darsow, Gayle M. Lorenzi, Terrie Kellmeyer, Karen Lutz, Yan Wang, Juan P. Frias> ;Diabetes Technology & Therapeutics. 2007 Apr 10
• 54 citations
  Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline ...
  Katarina Raslova, S. C Tamer, Per Clauson, Diane Karl> ;Clinical Drug Investigation. 2007 Jan 1
• 7 citations
  The use of bolus insulin and advancing insulin therapy in type 2 diabetes.
  Diane M. Karl> ;Current Diabetes Reports. 2004 Oct 1
• Insulin treatment for type 2 diabetes.
  J C Shipp, L Jovanovic> ;JAMA. 1998 May 20
• Insulin treatment for type 2 diabetes.
  I B Hirsch, T C Evans, B Gaster> ;JAMA. 1998 May 20
• Educational attainment in survivors of ALL.
  Challinor J, Karl D> ;JAMA. 1995-10-11
• 12 citations
  Fasting hypoglycemia associated with disopyramide.
  Jeffery D. Semel, Edward Wortham, Diane M Karl> ;American Heart Journal. 1983 Nov 1
• 12 citations
  Human pharmacology and clinical evaluation of an oral carbenicillin preparation.
  Jose L. Bran, Diane M. Karl> ;Clinical Pharmacology and Therapeutics. 1971 May 1
• Insulin treatment for type 2 diabetes.
  Riddle, M. C., Karl, D. M.> ;JAMA. 1998 May 20
• Join now to see all